Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

BiondVax Pharmaceuticals Q2 EPS $(0.003) Up From $(2.00) YoY

Author: Benzinga Newsdesk | August 11, 2023 09:02am
BiondVax Pharmaceuticals (NASDAQ:BVXV) reported quarterly losses of $(0.00) per share. This is a 99.85 percent increase over losses of $(2.00) per share from the same period last year.

Posted In: BVXV


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist